HC Wainwright Reiterates “Buy” Rating for Immunocore (NASDAQ:IMCR)
Immunocore (NASDAQ:IMCR – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $100.00 price target on the stock. HC Wainwright’s price target indicates a potential upside of 158.80% from the stock’s previous close. A number of other […]
Immunocore (NASDAQ:IMCR – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $100.00 price target on the stock. HC Wainwright’s price target indicates a potential upside of 158.80% from the stock’s previous close. A number of other […]
